Search

26 Jun 2024: said: “We are delighted to have closed the funding round with Cambridge Enterprise and the University of Cambridge Enterprise Fund. ... We are delighted to close this investment on behalf of the University of Cambridge Enterprise Fund.

26 Jun 2024: said: “We are delighted to have closed the funding round with Cambridge Enterprise and the University of Cambridge Enterprise Fund. ... We are delighted to close this investment on behalf of the University of Cambridge Enterprise Fund.

26 Jun 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... cells with single chromosome set/a appeared first on a

26 Jun 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... Cambridge, funding a post-doctoral researcher in Martin’s laboratory to work on the design and construction of the

26 Jun 2024: rel="noopener noreferrer"Cambridge Epigenetix/a,a pioneer in the development of epigenetic sequencing. ... It dates back almost 10 years before the anniversary that Cambridge Enterprise is now celebrating.

26 Jun 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... This drug has taken decades to develop, and we applaud the team at Cambridge for all their work in making it a reality.

26 Jun 2024: So that’s why, with the support of Cambridge Enterprise, we founded Healthera. ... University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals.

26 Jun 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... cells with single chromosome set/a appeared first on a

26 Jun 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... cells with single chromosome set/a appeared first on a

26 Jun 2024: the animal antibody with human equivalents – for the drug to be successful in humans. ... Cambridge researchers/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

26 Jun 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... cells with single chromosome set/a appeared first on a

20 Jun 2024: Images, including our videos, are Copyright University of Cambridge and licensors/contributors as identified. ... Email. I wish to receive a weekly Cambridge research news summary by email.

26 Jun 2024: cam.ac.uk/news/official-opening-of-cambridge-labs-at-sbc/ Ruth Jackson Thu, 20 Mar 2014 16:28:20 0000 Life Sciences Spin-outs Technology Transfer campus clare bryant drugs ... glaxosmithkline heat HEFCE hypersensitivity Johnson & Johnson leszek

26 Jun 2024: cam.ac.uk/news/wound-care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin Fri, 31 Mar 2023 12:47:26 0000 Life Sciences Spin-outs Ventures animals ... bandage Cambridge & Peterborough Combined Authority cambridge angels cattle

26 Jun 2024: Schmitt, Technology Manager at Cambridge Enterprise, the University’s commercialisation group, said “Studying the functions of genes in mammals is enormously difficult. ... Together they spent time speaking to potential life science customers based

26 Jun 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.

26 Jun 2024: rel="noopener noreferrer"Cycle Pharmaceuticals/a, a Cambridge-based company, the researchers identified six known molecules that they thought might inhibit the PARP enzymes. ... such acknowledged experts at the University of Cambridge and Kings College

26 Jun 2024: of Cambridge gene therapy spin-out is developing a treatment that could prevent the deleterious effects of glaucoma, the leading cause of irreversible blindness worldwide. ... across the research of Professor Martin of the Clinical Neurosciences Group at

26 Jun 2024: cam.ac.uk/news/wound-care-company-nobacz-healthcare-ltd-closes-2-7m-seed-round/ Jo Tramontin Fri, 31 Mar 2023 12:47:26 0000 Life Sciences Spin-outs Ventures animals ... round/a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge

26 Jun 2024: across the research of Professor Martin of the Clinical Neurosciences Group at the University of Cambridge and sought collaboration. ... a appeared first on a href="https://www.enterprise.cam.ac.uk"Cambridge Enterprise/a./p.